Related Experiment Video
Updated: Apr 4, 2026

05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.3K
Trends in Modern Drug Discovery
1Novartis Pharma AG, CH-4056, Basel, Switzerland.
Handbook of Experimental Pharmacology
|September 3, 2015
Summary
Modern drug discovery has shifted from serendipity to a hypothesis-driven, target-based approach using genomics and automation. This evolution, involving academia and industry, yields more first-in-class drugs for unmet medical needs.
Area of Science:
- Pharmacology and Drug Development
- Genomics and Bioinformatics
- Biotechnology
Background:
- Historically, drug discovery relied on ethnobotany and serendipity, often without specific targets or mechanisms.
- The pharmaceutical industry has undergone significant environmental changes over the past century.
- Advancements in molecular biology and human genome knowledge have revolutionized the field.
Purpose of the Study:
- To outline the evolution of drug discovery methodologies.
- To highlight the impact of technological advancements and genomics on modern drug development.
- To emphasize the collaborative efforts required for translating basic science into medical treatments.
Main Methods:
- Shift from target-agnostic to hypothesis-driven, target-based approaches.
- Increased use of computerization and automation in research laboratories.
- Clustering of dispersed research sites into large centers for synergy.
Main Results:
- A significant increase in the number of first-in-class drugs approved in recent years.
- Demonstrated impact of modern drug discovery approaches, technologies, and genomics.
- Successful translation of basic science into novel medical treatments for unmet needs.
Conclusions:
- Modern drug discovery is a complex, multidisciplinary effort involving academia, regulatory agencies, and industry.
- A critical mass of scientists and technological integration are essential for pharmaceutical companies to discover breakthrough medicines.
- The field continues to advance, promising further improvements in medicine and patient care.
Keywords:
Lead discoveryPharmaceutical industryPharmaceutical researchPhenotypic screeningR&D productivityTarget discoveryTarget-based drug discoveryMore Related Videos
Related Concept Videos
Drug Discovery: Overview
13.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.3K
Structure-Activity Relationships and Drug Design
2.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.1K
Pharmacogenomics: Identification of New Drug Targets
86
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86
Drug Administration and Therapy Phases: Overview
1.7K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.7K
Preclinical Development: Overview
6.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.5K
Drug Regulation
3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K

